Effects of Exenatide Long-Acting Release on Glucose Control and Safety in Subjects With Type 2 Diabetes Mellitus(DURATION - 1)

NCT00308139 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

303

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: exenatide, long acting release
DRUG: exenatide

Sponsor

AstraZeneca